AstraZeneca Chair: Shareholders can ‘vote me away’

As AstraZeneca‘s shares tumbled following its rejection of Pfizer‘s increased bid, the company’s chairman told CNBC that shareholders had the right to “vote me away” if they were unhappy.

Leif Johansson said that AstraZeneca had discussed the takeover bid with shareholders throughout May, and was “reasonably happy” that its decision to reject the deal was the right one.

Pfizer has pursued its U.K. rival for months, in its attempt to create the world’s largest drugs company. On Monday, AstraZeneca’s rejected the U.S. giant’s “final” bid of £69 billion ($116 billion), worth £55 per share.

This is developing news story. Please check back for updates.

Bloomberg contributor | Bloomberg | Getty Images

Bloomberg contributor | Bloomberg | Getty Images

This entry was posted in M&A. Bookmark the permalink.

Leave a Reply